Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Meves, Saskia H ^a   Neubauer, Horst ^a   Overbeck, Ursula ^a   Endres, Heinz G ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Aggregometry; Aspirin; Loading Dose; Pharmacokinetics; Stroke

Indexed keywords

EID: 79953283772     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-106     Document Type: Article

References (32)

1. CAST: a randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group, Lancet 1997 349 9066 1641 1649 10.1016/S0140-6736(97)04010- 5 9186381
2. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group, Lancet 1997 349 9065 1569 1581 10.1016/S0140-6736(97)04011-7 9174558
3. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. ZM Chen P Sandercock HC Pan C Counsell R Collins LS Liu JX Xie C Warlow R Peto, Stroke 2000 31 6 1240 1249 10835439 (Pubitemid 30351240)
4. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. HP Adams Jr G del Zoppo MJ Alberts DL Bhatt L Brass A Furlan RL Grubb RT Higashida EC Jauch C Kidwell PD Lyden LB Morgenstern AI Qureshi RH Rosenwasser PA Scott EF Wijdicks American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups, Stroke 2007 38 5 1655 1711 10.1161/STROKEAHA.107.181486 17431204 (Pubitemid 46691097)
5. Gemeinsame Leitlinie der Deutschen Gesellschaft für Neurologie und der Deutschen Schlaganfallgesellschaft. Akuttherapie des ischämischen Schlaganfalls. Deutsche Gesellschaft für Neurologie (DGN), Deutsche Schlaganfallgesellschaft (DSG), Leitlinien für Diagnostik und Therapie in der Neurologie Georg Thieme Verlag, Diener HC, Putzki N, Berlit P, 2008 243 260
6. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee, Cerebrovasc Dis 2008 25 5 457 507 10.1159/000131083 18477843
7. Secondary Prevention of Stroke and Transient Ischemic Attack: Is More Platelet Inhibition the Answer? JK Liao, Circulation 2007 115 12 1615 1621 10.1161/CIRCULATIONAHA.106.653741 17389280 (Pubitemid 46648647)
8. Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on the monitoring of aspirin antiplatelet therapy. J Golaski S Chopicki R Golaski P Gresner A Iwaszkiewicz C Watala, Ther Drug Monit 2005 27 4 484 490 16044106 (Pubitemid 41098824)
9. Determination of aspirin responsiveness by use of whole blood platelet aggregometry. BT Ivandic E Giannitsis P Schlick P Staritz HA Katus T Hohlfeld, Clin Chem 2007 53 4 614 619 10.1373/clinchem.2006.081059 17332149 (Pubitemid 46580230)
10. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. W Kuliczkowski A Witkowski L Polonski C Watala K Filipiak A Budaj J Golanski D Sitkiewicz J Pregowski J Gorski M Zembala G Opolski K Huber H Arnesen SD Kristensen R De Caterina, Eur Heart J 2009 30 4 426 435 10.1093/eurheartj/ ehn562 19174428
11. Methods to evaluate the pharmacology of oral antiplatelet drugs. AA Weber M Adamzik HS Bachmann K Görlinger M Grandoch K Leineweber H Müller-Beissenhirtz F Wenzel C Naber Interdisciplinary Study Group - Clinical Pharmacology of Haemostasis, Herz 2008 33 4 287 296 10.1007/s00059-008-3132-2 18581078 (Pubitemid 351929668)
12. Variable platelet response to aspirin in patients with ischemic stroke. T Hohlfeld AA Weber U Junghans M Schumacher M Boucher K Schrör M Siebler, Cerebrovasc Dis 2007 24 1 43 50 10.1159/000103115 17519543 (Pubitemid 47026140)
13. Antiplatelet effect of aspirin in patients with cerebrovascular disease. MJ Alberts DL Bergman E Molner BD Jovanovic I Ushiwata J Teruya, Stroke 2004 35 1 175 178 10.1161/01.STR.0000106763.46123.F6 14671242 (Pubitemid 38057615)
14. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. FM Gengo M Rainka M Robson MF Gengo A Forrest M Hourihane V Bates, J Clin Pharmacol 2008 48 3 335 343 10.1177/0091270007313324 18223144 (Pubitemid 351257777)
15. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. KH Grotemeyer HW Scharafinski IW Husstedt, Thromb Res 1993 71 5 397 403 10.1016/0049-3848(93)90164-J 8236166
16. Failure of aspirin treatment after stroke. NM Bornstein VG Karepov BD Aronovich AY Gorbulev TA Treves AD Korczyn, Stroke 1994 25 29 275 277 8303730 (Pubitemid 24047244)
17. Development of aspirin resistance in persons with previous ischemic stroke. CM Helgason KM Bolin JA Hoff SR Winkler A Mangat KL Tortorice LD Brace, Stroke 1994 25 12 2331 2336 7974569 (Pubitemid 24359298)
18. Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing. T Komiya M Kudo T Urabe Y Mizuno, Stroke 1994 25 12 2337 2342 7974570
19. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. C Patrono B Coller JE Dalen GA FitzGerald V Fuster M Gent J Hirsh G Roth, Chest 2001 119 1 Suppl 39S 63S 10.1378/chest.119.1-suppl.39S 11157642 (Pubitemid 32154194)
20. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. AK Pedersen GA FitzGerald, N Engl J Med 1984 311 19 1206 1211 10.1056/NEJM198411083111902 6436696 (Pubitemid 14021923)
21. Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt. L Aarons K Hopkins M Rowland S Brossel JF Thiercelin, Pharm Res 1989 6 8 660 666 10.1023/A:1015978104017 2510140 (Pubitemid 19253876)
22. Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man. RH Böger SM Bode-Böger FM Gutzki D Tsikas HP Weskott JC Frölich, Clin Sci (Lond) 1993 84 5 517 24 8504628 (Pubitemid 23131964)
23. Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers. JL Coleman MJ Alberts, Am J Cardiol 2006 98 6 838 841 10.1016/j.amjcard.2006.03.071 16950199 (Pubitemid 44301025)
24. Role of drug absorption in the pharmacokinetics of therapeutic interventions for stroke. DJ Conrado D Gonzalez H Derendorf, Ann N Y Acad Sci 2010 1207 134 142 10.1111/j.1749-6632.2010.05729.x 20955436
25. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. NH Wallén C Held N Rehnqvist P Hjemdahl, Eur Heart J 1997 18 5 807 815 9152651 (Pubitemid 27208153)
26. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. AJ Coull JK Lovett PM Rothwell Oxford Vascular Study, BMJ 2004 328 7435 326 10.1136/bmj.37991.635266.44 14744823
27. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. MF Giles PM Rothwell, Lancet Neurol 2007 6 12 1063 1072 10.1016/S1474-4422(07)70274-0 17993293 (Pubitemid 350116693)
28. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. PM Rothwell MF Giles A Chandratheva L Marquardt O Geraghty JN Redgrave CE Lovelock LE Binney LM Bull FC Cuthbertson SJ Welch S Bosch FC Alexander LE Silver SA Gutnikov Z Mehta Early use of Existing Preventive Strategies for Stroke (EXPRESS) study, Lancet 2007 370 9596 1432 1442 10.1016/S0140-6736(07)61448-2 17928046 (Pubitemid 47576154)
29. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). JD Douketis PB Berger AS Dunn AK Jaffer AC Spyropoulos RC Becker J Ansell American College of Chest Physicians, Chest 2008 133 6 Suppl 299S 339S 10.1378/chest.08-0675 18574269 (Pubitemid 351894915)
30. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction. C Jmbor CF Weber K Gerhardt W Dietrich M Spannagl B Heindl B Zwissler, Anesth Analg 2009 109 1 25 31 19439684
31. Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures. T Komatsu Y Tamai H Takami K Yamagata S Fukuda A Munakata, J Gastroenterol 2005 40 7 698 707 10.1007/s00535-005-1613-0 16082586 (Pubitemid 41349081)
32. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. E Zisman A Erport E Kohanovsky M Ballagulah A Cassel M Quitt R Pizov, Eur J Anaesthesiol 2010 27 7 617 623 10.1097/EJA.0b013e328335b354 20035230